SEC Form 4 · accession 0001144204-15-068109
Edesa Biotech, Inc. · EDSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank R. Oakes
Officer — President, CEO & Director · Director
Period of report
Nov 24, 2015
Accepted (ET)
Nov 25, 2015 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001540159
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | Nov 24, 2015 | X | 150,000 | $2.50 | D | 193,965 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Call Option (Obligation to Sell) | $2.50 | Nov 24, 2015 | X | 150,000 | D | Nov 26, 2012 | Nov 25, 2015 | Common Shares | 150,000 | 0 | D |